Related Experiment Video
Updated: Feb 27, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
17.4K
Consensus Molecules Associated with Parkinson's Disease.
Sara Eyal1, Shira Alfasi1, Karin Ben Zaken1
1Azrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Neurology International
|February 26, 2026
Summary
This study analyzed the Human Metabolome Database to find associations between Parkinson's disease (PD) and various compounds. It identified numerous drugs, biomarkers, and chemical inducers linked to PD, offering new research directions.
Area of Science:
- * Metabolomics and Neurodegenerative Diseases
- * Pharmacology and Toxicology
- * Biochemistry of Neurodegeneration
Background:
- * Parkinson's disease (PD) is a complex neurodegenerative disorder.
- * Existing research suggests potential links between PD and environmental factors, including specific foods and drugs.
- * A comprehensive understanding of these associations is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- * To systematically investigate the associations between Parkinson's disease and a wide range of chemical compounds.
- * To leverage the Human Metabolome Database (HMDB) and PubMed for a large-scale co-citation analysis.
- * To identify specific drugs, biomarkers, and endogenous molecules associated with PD.
Main Methods:
- * Utilized a comprehensive list of 217,776 compounds from the Human Metabolome Database (HMDB).
- * Developed a Python script to query PubMed for co-citations between Parkinson's disease (PD) and each compound.
- * Adjusted co-citation counts based on compound abundance to refine association strength.
Main Results:
- * Identified significant associations between PD and various compound categories: small-molecule drugs, adjunctive therapies, contraindicated drugs, diagnostic agents, biomarkers, conditional essential molecules, and inducers.
- * Highlighted specific drugs like L-dopa, carbidopa, entacapone, rasagiline, ropinirole, and pramipexole with high association percentages.
- * Confirmed known PD inducers such as 6-hydroxydopamine (6-OHDA), MPTP, and rotenone, and identified others like salsolinol and BMAA.
Conclusions:
- * This study provides a data-driven overview of compounds associated with Parkinson's disease.
- * The findings underscore the importance of specific drugs and endogenous molecules in PD pathogenesis and progression.
- * Highlights conditional essential endogenous cofactors and suggests rational directions for future PD research.
More Related Videos
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
8.0K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.3K
Related Concept Videos
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:37Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
01:19Brainstem
7.1K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
7.1K
01:22Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K